An interventional study of Carbohydrate and Carbohydrate and protein ingestion in Exercise Recovery, sponsored by Maastricht University Medical Center. Completed at 1 site in Netherlands. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-04-14.
Sponsored by Maastricht University Medical Center · Not applicable, Interventional, and Basic science
The aim of the present study is to investigate the effect of added protein+leucine or caffeine to 1.2 g/kg/h CHO on the rate of post-exercise muscle glycogen re-synthesis in healthy, recreational athletes.
The investigators hypothesize that both interventions (the addition of caffeine or protein+leucine) will lead to higher glycogen re-synthesis compared to the ingestion of CHO only, and that the co-ingestion of protein and leucine will result in the highest muscle glycogen synthesis rates.
Maastricht University Medical Center is the lead sponsor of 835 studies on the registry; 122 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Carbohydrate ingestion
Dietary Supplement: Carbohydrate
Carbohydrate and protein ingestion
Dietary Supplement: Carbohydrate and protein ingestion
Carbohydrate and caffeine ingestion
Dietary Supplement: Carbohydrate and caffeine ingestion
1.2 g/kg/h
1.2 g/kg/h carbohydrate plus 0.4 g/kg/h protein
1.2 g/kg/h carbohydrate and 1.67 g/kg/h caffeine
Muscle glycogen synthesis rates
Time frame: 6 hours
Glycogen synthase activity, plasma glucose, insulin, free fatty acids and epinephrine responses
Time frame: 6 hours
This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Maastricht University Medical Center